Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-05-29
2007-05-29
Fay, Zohreh (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S912000
Reexamination Certificate
active
11200739
ABSTRACT:
The topical use of glycosides for the treatment of dry eye disorders is disclosed.
REFERENCES:
patent: 4131651 (1978-12-01), Shah et al.
patent: 4370325 (1983-01-01), Packman
patent: 4409205 (1983-10-01), Shively
patent: 4744980 (1988-05-01), Holly
patent: 4818537 (1989-04-01), Guo
patent: 4883658 (1989-11-01), Holly
patent: 4914088 (1990-04-01), Glonek et al.
patent: 4966773 (1990-10-01), Gressel et al.
patent: 5041434 (1991-08-01), Lubkin
patent: 5075104 (1991-12-01), Gressel et al.
patent: 5174988 (1992-12-01), Mautone et al.
patent: 5278151 (1994-01-01), Korb et al.
patent: 5290572 (1994-03-01), MacKeen
patent: 5294607 (1994-03-01), Glonek et al.
patent: 5371108 (1994-12-01), Korb et al.
patent: 5405878 (1995-04-01), Ellis et al.
patent: 5538721 (1996-07-01), Babcock et al.
patent: 5578586 (1996-11-01), Glonek et al.
patent: 5597808 (1997-01-01), Haimes et al.
patent: 5631004 (1997-05-01), Cagle et al.
patent: 5696166 (1997-12-01), Yanni et al.
patent: 5780467 (1998-07-01), Dorn et al.
patent: 5800807 (1998-09-01), Hu et al.
patent: 5840054 (1998-11-01), Hamano et al.
patent: 5958912 (1999-09-01), Sullivan
patent: 5985259 (1999-11-01), Cagle et al.
patent: 6022862 (2000-02-01), Haimes et al.
patent: 6153607 (2000-11-01), Pflugfelder et al.
patent: 6235735 (2001-05-01), Dorn et al.
patent: 6277365 (2001-08-01), Ellis et al.
patent: 6432970 (2002-08-01), Beachy et al.
patent: 6599879 (2003-07-01), Jimenez et al.
patent: 6630135 (2003-10-01), Cagle et al.
patent: 6638930 (2003-10-01), Dorn et al.
patent: WO 00/03705 (2000-01-01), None
Lemp, “Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes,”CLAO Journal, vol. 21(4), pp. 221-231 (1995).
McCulley et al., “Tear Film Structure and Dry Eye,”Contactologiavol. 20, pp. 145-149 (1998).
Marsh et al., “Topical Nonpreserved Methylprednisolone Therapy for Keratoconjunctivitis Sicca in Sjogren Syndrome,”Ophthalmology, vol. 106(4), pp. 811-816 (1999).
Shine et al., “Keratoconjunctivitis Sicca Associated with Meibomian Secretion Polar Lipid Abnormality,”Arch. Ophthalmol.vol. 116, pp. 849-852 (1998).
Tauber et al.,Lacrimal Gland, Tear Film and Dry Eye Syndromes 2, Plenum Press, New York (1998), “A Dose-Ranging Clinical Trial to Assess the Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients with Keratoconjunctivitis Sicca,” pp. 969-972.
Alcon Inc.
Fay Zohreh
Ryan Patrick M.
LandOfFree
Method of treating dry eye disorders using glycosides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating dry eye disorders using glycosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating dry eye disorders using glycosides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3750539